Apolipoprotein E, brain injury and neurodevelopmental outcome of children

M. Korja*, M. Ylijoki, H. Lapinleimu, P. Pohjola, J. Matomäki, H. Kuśmierek, M. Mahlman, H. Rikalainen, R. Parkkola, T. Kaukola, L. Lehtonen, M. Hallman, L. Haataja

*Corresponding author for this work

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Apolipoprotein E plays an important role in neurodegenerative processes in adulthood, whereas its neurodevelopmental role is uncertain. We aimed to study the effect of apolipoprotein E on neurodevelopment in a cohort liable to neurodevelopmental changes. The cohort consisted of very preterm (<32 gestational weeks) and/or very low birth weight (<1500g) children, and the longitudinal follow-up protocol included sequential cranial ultrasounds during infancy, brain magnetic resonance imaging at term-equivalent age, neurological and cognitive assessment (Mental Developmental Index) at the corrected age of 2 years and cognitive and neuropsychological assessments (Wechsler Preschool and Primary Scale of Intelligence and Developmental NEuroPSYchological Assessment) at the chronological age of 5 years. Apolipoprotein E genotypes were determined from 322 children. Ultrasound and magnetic resonance imaging data were available for 321 (99.7%) and 151 (46.9%) children, respectively. Neurodevelopmental assessment data were available for 138 (42.9%) to 171 (53.1%) children. Abnormal findings in ultrasounds and magnetic resonance imaging were found in 163 (50.8%) and 64 (42.4%) children, respectively. Mild cognitive delay at the corrected age of 2 years and the chronological age of 5 years was suspected in 21 (12.3%) of 171 and 19 (13.8%) of 138 children, respectively. In the Developmental NEuroPSYchological Assessment, 47 (32.6%) of 144 children had significantly impaired performances in more than one study subtest. No associations between the apolipoprotein E genotypes and imaging findings or measured neurodevelopmental variables were found. Apolipoprotein E genotypes do not appear to have major impact on brain vulnerability or neurodevelopment in children.

    Original languageEnglish
    Pages (from-to)348-352
    Number of pages5
    JournalGenes, Brain and Behavior
    Volume12
    Issue number3
    DOIs
    Publication statusPublished - Apr 2013

    Keywords

    • APOE
    • Apolipoprotein E
    • Brain injury
    • BSID-II, FSIQ
    • Genotype
    • Neurodevelopment
    • Preterm
    • Very low birth weight

    Fingerprint Dive into the research topics of 'Apolipoprotein E, brain injury and neurodevelopmental outcome of children'. Together they form a unique fingerprint.

  • Cite this

    Korja, M., Ylijoki, M., Lapinleimu, H., Pohjola, P., Matomäki, J., Kuśmierek, H., ... Haataja, L. (2013). Apolipoprotein E, brain injury and neurodevelopmental outcome of children. Genes, Brain and Behavior, 12(3), 348-352. https://doi.org/10.1111/gbb.12024